These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9184730)

  • 21. Efficacy and safety of once-daily vs twice-daily dosing with fluvastatin, a synthetic reductase inhibitor, in primary hypercholesterolemia.
    Insull W; Black D; Dujovne C; Hosking JD; Hunninghake D; Keilson L; Knopp R; McKenney J; Stein E; Troendle AJ
    Arch Intern Med; 1994 Nov; 154(21):2449-55. PubMed ID: 7979841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Creatine kinase elevation caused by a combination of fluvastatin and telmisartan in a patient heterozygous for the CYP2C9*3 and ABCC2 -24C > T variants: a case report.
    Meyer zu Schwabedissen HE; Siegmund W; Kroemer HK; Rollnik JD
    BMC Res Notes; 2014 Oct; 7():688. PubMed ID: 25280537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute pancreatitis induced by fluvastatin therapy.
    Tysk C; Al-Eryani AY; Shawabkeh AA
    J Clin Gastroenterol; 2002; 35(5):406-8. PubMed ID: 12394230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of clopidogrel on the steady-state pharmacokinetics of fluvastatin.
    Ayalasomayajula SP; Vaidyanathan S; Kemp C; Prasad P; Balch A; Dole WP
    J Clin Pharmacol; 2007 May; 47(5):613-9. PubMed ID: 17442686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for new targets and synergistic effect of metronomic celecoxib/fluvastatin combination in pilocytic astrocytoma.
    Mercurio S; Padovani L; Colin C; Carré M; Tchoghandjian A; Scavarda D; Lambert S; Baeza-Kallee N; Fernandez C; Chappé C; André N; Figarella-Branger D
    Acta Neuropathol Commun; 2013 May; 1():17. PubMed ID: 24252689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia.
    Hsu I; Spinler SA; Johnson NE
    Ann Pharmacother; 1995; 29(7-8):743-59. PubMed ID: 8520093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of fluvastatin and bezafibrate combination on plasma fibrinogen, t-plasminogen activator inhibitor and C reactive protein levels in coronary artery disease patients with mixed hyperlipidaemia (FACT study). Fluvastatin Alone and in Combination Treatment.
    Cortellaro M; Cofrancesco E; Boschetti C; Cortellaro F; Mancini M; Mariani M; Paoletti R
    Thromb Haemost; 2000 Apr; 83(4):549-53. PubMed ID: 10780315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of fluvastatin in patients undergoing high-risk non-cardiac surgery.
    Voûte MT; Winkel TA; Poldermans D
    Expert Opin Drug Saf; 2010 Sep; 9(5):793-800. PubMed ID: 20557267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and tolerability of fluvastatin XL 80 mg alone, ezetimibe alone, and the combination of fluvastatin XL 80 mg with ezetimibe in patients with a history of muscle-related side effects with other statins.
    Stein EA; Ballantyne CM; Windler E; Sirnes PA; Sussekov A; Yigit Z; Seper C; Gimpelewicz CR
    Am J Cardiol; 2008 Feb; 101(4):490-6. PubMed ID: 18312764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is decreased libido associated with the use of HMG-CoA-reductase inhibitors?
    de Graaf L; Brouwers AH; Diemont WL
    Br J Clin Pharmacol; 2004 Sep; 58(3):326-8. PubMed ID: 15327593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The interaction of fluvastatin and cyclosporin A in renal transplant patients.
    Li PK; Mak TW; Wang AY; Lee YT; Leung CB; Lui SF; Lam CW; Lai KN
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):246-8. PubMed ID: 7620696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increases in creatine kinase after exercise in patients treated with HMG Co-A reductase inhibitors.
    Thompson PD; Nugent AM; Herbert PN
    JAMA; 1990 Dec; 264(23):2992. PubMed ID: 2243421
    [No Abstract]   [Full Text] [Related]  

  • 33. Rosuvastatin-warfarin drug interaction.
    Barry M
    Lancet; 2004 Jan; 363(9405):328. PubMed ID: 14751711
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of fluvastatin, a new inhibitor of HMG-CoA reductase, and niceritrol on serum lipids, lipoproteins and cholesterol ester transfer activity in primary hypercholesterolemic patients.
    Sasaki J; Yamamoto K; Kobori S; Setoguchi Y; Sato Y; Matsunaga A; Shichiri M; Sakai T; Kono S; Arakawa K
    Int J Clin Pharmacol Ther; 1995 Jul; 33(7):420-6. PubMed ID: 7582401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of fluvastatin on 24-week telaprevir-based combination therapy for hepatitis C virus genotype 1b-infected chronic hepatitis C.
    Atsukawa M; Tsubota A; Shimada N; Kondo C; Itokawa N; Nakagawa A; Fukuda T; Matsushita Y; Narahara Y; Osada Y; Yamaguchi H; Nakatsuka K; Iwakiri K; Kawamoto C; Sakamoto C
    Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):781-7. PubMed ID: 24732752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Not just decreased LDL level is decisive. Which statin for patients at risk for coronary disease?].
    MMW Fortschr Med; 2004 Jun; 146(24):1-3. PubMed ID: 15366507
    [No Abstract]   [Full Text] [Related]  

  • 37. Chronic cough as a complication of treatment with statins: a case report.
    Psaila M; Fsadni P; Montefort S
    Ther Adv Respir Dis; 2012 Aug; 6(4):243-6. PubMed ID: 22761129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Marked elevation of liver transaminases after high-dose fluvastatin unmasks chronic hepatitis C: safety and re-challenge.
    Chen YW; Lai HW; Wang TD
    Acta Neurol Taiwan; 2007 Sep; 16(3):163-7. PubMed ID: 17966956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and pharmacology of fluvastatin.
    Jokubaitis LA
    Br J Clin Pract Suppl; 1996 Jan; 77A():11-5. PubMed ID: 8729584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluvastatin treatment is not associated with an increased incidence of cancer.
    Stein EA; Corsini A; Gimpelewicz CR; Bortolini M; Gil M
    Int J Clin Pract; 2006 Sep; 60(9):1028-34. PubMed ID: 16939542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.